AEHR
Aehr TestFDocument history
Earnings documents stored for AEHR.
Investor releaseQuarter not tagged2026-08-11Aehr Test Systems Surges on Tuesday as the Optics Earnings Season Heats Up
24/7 Wall St.
Aehr Test Systems Surges on Tuesday as the Optics Earnings Season Heats Up
AEHR surged 426% year to date after guiding fiscal 2027 revenue to a range of $130 million to $150 million, implying up to 200% year-over-year growth. Record Q4 bookings of $60.7 million pushed backlog to $100.6 million, already covering 77% of minimum fiscal 2027 revenue guidance. With a P/S ratio of 69 and a fair value estimate of $18, insider selling and a shelf filing signal caution at current levels. It sounds nuts, but SoFi1 is giving new Active Invest users up to $3,000 in stock for a limited time, and all it takes is a $50 deposit to get started.2 See for yourself (Sponsor) Shares of Aehr Test Systems (NASDAQ:AEHR) are up 6.1% in midday trading Tuesday, extending a torrid summer run in the semiconductor test equipment name. The stock now trades near $116, closing in on its 52-week high of $126.62 after a fresh wave of buying tied to the company's AI burn-in and silicon photonics story. The move builds on a blowout fiscal Q4 report. Aehr delivered Q4 revenue of $18.84 million, swung back to profitability with net income of $1.39 million, and posted EPS of $0.11 against expectations for a narrow gain. Record Q4 bookings of $60.7 million pushed effective backlog to $100.6 million, giving the company visibility into a much larger fiscal 2027. Management's forward outlook is what changed the stock's ceiling. Aehr guided fiscal 2027 revenue to $130 million to $150 million, implying 160% to 200% year-over-year growth. CEO Gayn Erickson has been clear about the driver: "We are very pleased with the strong momentum in our business across multiple market segments, highlighted by more than $37 million in quarterly bookings and a book-to-bill ratio exceeding 3.5x." AI processors and silicon photonics testing together accounted for 91% of Q4 revenue, a dramatic mix shift from the silicon carbide-heavy business investors bought two years ago. SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $3,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. (Sponsor) Here is where the story gets more complicated, and why the stock has been so volatile. Aehr is now one of the purest public plays on optical interconnects for hyperscale AI, a corner of the market that has been swinging on every headline. On August 4, Aehr announced a follow-on production order…Read full documentShow less
AEHR surged 426% year to date after guiding fiscal 2027 revenue to a range of $130 million to $150 million, implying up to 200% year-over-year growth. Record Q4 bookings of $60.7 million pushed backlog to $100.6 million, already covering 77% of minimum fiscal 2027 revenue guidance. With a P/S ratio of 69 and a fair value estimate of $18, insider selling and a shelf filing signal caution at current levels. It sounds nuts, but SoFi1 is giving new Active Invest users up to $3,000 in stock for a limited time, and all it takes is a $50 deposit to get started.2 See for yourself (Sponsor) Shares of Aehr Test Systems (NASDAQ:AEHR) are up 6.1% in midday trading Tuesday, extending a torrid summer run in the semiconductor test equipment name. The stock now trades near $116, closing in on its 52-week high of $126.62 after a fresh wave of buying tied to the company's AI burn-in and silicon photonics story. The move builds on a blowout fiscal Q4 report. Aehr delivered Q4 revenue of $18.84 million, swung back to profitability with net income of $1.39 million, and posted EPS of $0.11 against expectations for a narrow gain. Record Q4 bookings of $60.7 million pushed effective backlog to $100.6 million, giving the company visibility into a much larger fiscal 2027. Management's forward outlook is what changed the stock's ceiling. Aehr guided fiscal 2027 revenue to $130 million to $150 million, implying 160% to 200% year-over-year growth. CEO Gayn Erickson has been clear about the driver: "We are very pleased with the strong momentum in our business across multiple market segments, highlighted by more than $37 million in quarterly bookings and a book-to-bill ratio exceeding 3.5x." AI processors and silicon photonics testing together accounted for 91% of Q4 revenue, a dramatic mix shift from the silicon carbide-heavy business investors bought two years ago. SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $3,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. (Sponsor) Here is where the story gets more complicated, and why the stock has been so volatile. Aehr is now one of the purest public plays on optical interconnects for hyperscale AI, a corner of the market that has been swinging on every headline. On August 4, Aehr announced a follow-on production order from its lead silicon photonics customer for a fully automated FOX-XP multi-wafer system with nine independent WaferPak test blades, expected to ship in the first half of 2027. Erickson framed the order as evidence that silicon photonics is moving "from technology adoption to manufacturing scale-up." That announcement sent shares up 57% in the days that followed, and the stock is now up 15.8% over the past week and 46% over the past month. Year to date, AEHR is up an eye-watering 426%. But optical and photonics names have traded in violent back-and-forth patterns all summer, whipsawing on hyperscaler capex commentary, competitive positioning, and shifting expectations for co-packaged optics timelines. With a beta of 3.1, Aehr amplifies every move in the group. The bull case is that backlog now covers roughly 77% of the minimum fiscal 2027 guidance, and while Aehr is expensive, it also has several new ramping markets into the future and has displayed strong recent execution. The bear case has teeth too. The company trades at a price-to-sales ratio of 69. Insiders have been trimming into strength: director Howard T. Slayen sold 20,000 shares at $108.30 on August 4, and Aehr filed an omnibus shelf registration on July 31, signaling flexibility to raise capital. Wall Street coverage remains constructive. The analyst target price sits at $115, with three buy ratings and one hold. That target is essentially at the stock, meaning further upside now depends on estimates catching up to the fiscal 2027 ramp. Looking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open a new Active Invest account, fund it with $50 or more, and you could receive up to $3,000 in complimentary stock. From $0 commission trading3 to fractional shares4 and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus.(Sponsor) Contact [email protected] for any questions or corrections.
Investor releaseQuarter not tagged2026-07-17Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
MarketBeat
Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
Interested in Aehr Test Systems? Here are five stocks we like better. Aehr Test Systems shares jumped nearly 22% after the company beat earnings estimates and issued strong fiscal 2027 revenue guidance of $130 million to $150 million. Aehr's fourth-quarter revenue grew 33.7% year-over-year to $18.84 million, while adjusted gross margin soared 1,000 basis points to 45%, aided by AI-related demand. Aehr's forward price-to-sales ratio has fallen about 56% from its peak, and analysts at Craig Hallum and Lake Street Capital set price targets implying roughly 40% upside. As AI stocks swing up and down, one name that has felt those movements as much as any is Aehr Test Systems (NASDAQ: AEHR). This small stock has risen about 320% in 2026, and sits at a market capitalization of $2.7 billion in mid-July. Though shares have been in a downtrend over the past 30 days, they saw a huge rebound after Aehr posted its latest earnings report, spiking nearly 22% in a single day. → Cintas Keeps Beating Expectations—And the Story Isn’t Over Aehr’s large move came as it surpassed estimates during the quarter and issued inspiring guidance. This guidance meaningfully changes how investors should view Aehr’s valuation and increases confidence in its outlook. → Sandisk: What the Chart Is Trying to Tell Us Aehr makes machines that put semiconductors under intense conditions, testing them for defects. As data center operators look to increase performance by weeding out faulty chips, Aehr has been gaining considerable order momentum. In Q4 of its fiscal year 2026 (FY2026), Aehr posted revenue of $18.84 million. (Note that Aehr’s fiscal reporting period is several quarters ahead of the calendar year period.) This resulted in growth of 33.7% year-over-year (YOY). → MarketBeat Week in Review – 07/13- 07/17 Notably, this marks the first time in over a year that Aehr’s quarterly revenue growth was positive, an important inflection for its business. However, analysts expected this performance, with Aehr just slightly beating estimates of $18.69 million. Alongside this, Aehr crushed estimates on earnings per share (EPS). The figure came in at 11 cents, swinging strongly from -1 cent a year ago. Analysts anticipated that EPS would remain unchanged at -1 cents. This came as Aehr greatly outperformed on adjusted gross margin, which soared 1,000 basis points to 45%, driven by higher sales, improve…Read full documentShow less
Interested in Aehr Test Systems? Here are five stocks we like better. Aehr Test Systems shares jumped nearly 22% after the company beat earnings estimates and issued strong fiscal 2027 revenue guidance of $130 million to $150 million. Aehr's fourth-quarter revenue grew 33.7% year-over-year to $18.84 million, while adjusted gross margin soared 1,000 basis points to 45%, aided by AI-related demand. Aehr's forward price-to-sales ratio has fallen about 56% from its peak, and analysts at Craig Hallum and Lake Street Capital set price targets implying roughly 40% upside. As AI stocks swing up and down, one name that has felt those movements as much as any is Aehr Test Systems (NASDAQ: AEHR). This small stock has risen about 320% in 2026, and sits at a market capitalization of $2.7 billion in mid-July. Though shares have been in a downtrend over the past 30 days, they saw a huge rebound after Aehr posted its latest earnings report, spiking nearly 22% in a single day. → Cintas Keeps Beating Expectations—And the Story Isn’t Over Aehr’s large move came as it surpassed estimates during the quarter and issued inspiring guidance. This guidance meaningfully changes how investors should view Aehr’s valuation and increases confidence in its outlook. → Sandisk: What the Chart Is Trying to Tell Us Aehr makes machines that put semiconductors under intense conditions, testing them for defects. As data center operators look to increase performance by weeding out faulty chips, Aehr has been gaining considerable order momentum. In Q4 of its fiscal year 2026 (FY2026), Aehr posted revenue of $18.84 million. (Note that Aehr’s fiscal reporting period is several quarters ahead of the calendar year period.) This resulted in growth of 33.7% year-over-year (YOY). → MarketBeat Week in Review – 07/13- 07/17 Notably, this marks the first time in over a year that Aehr’s quarterly revenue growth was positive, an important inflection for its business. However, analysts expected this performance, with Aehr just slightly beating estimates of $18.69 million. Alongside this, Aehr crushed estimates on earnings per share (EPS). The figure came in at 11 cents, swinging strongly from -1 cent a year ago. Analysts anticipated that EPS would remain unchanged at -1 cents. This came as Aehr greatly outperformed on adjusted gross margin, which soared 1,000 basis points to 45%, driven by higher sales, improved manufacturing capacity utilization, and a higher-margin product mix. Despite Aehr’s impressive quarter, full FY2026 revenue declined 15% YOY to $50 million. Aehr’s business has been transitioning from an overwhelming focus on EV markets to one overwhelmingly focused on non-EV markets, including AI. Aehr’s Q4 FY2026 results were strong, but the company’s guidance is what really stole the show. In FY2027, Aehr expects to generate full-year sales of between $130 million and $150 million. This would be a 160%-200% increase over FY2026. This guidance crystallizes Aehr’s success in generating orders for its Sonoma and FOX-XP systems. Over the past few quarters, Aehr has repeatedly announced significant orders within the AI chip industry. This has led to the company making strong statements about bookings, such as that second-half FY2026 bookings would come in “at the high end of its $60 million to $80 million range.” A record $41 million hyperscaler order allowed it to surpass that estimate. Aehr’s huge revenue guidance figure provides a clean metric that shows how far the company has come. Another figure that underpins this confidence is Aehr’s effective backlog of $100.6 million. The company simply has to deliver these booked orders to realize the revenue, absent cancellations. Assuming Aehr ships its full order backlog in FY2027, it would account for 67% to 77% of the company’s revenue guidance. This provides a strong degree of visibility into Aehr meeting its revenue expectations. It is important to note, though, that Aehr did not explicitly say that its full backlog would necessarily convert in FY2027. The additional customer demand Aehr anticipates for the rest of the year is the difference between its backlog and guidance. Notably, the company stated that it sees an opportunity to raise its guidance even higher in FY2027. Aehr expects its adjusted pretax profitability to be between 18% and 22% of revenue in FY2027. At the midpoint, this would imply adjusted pretax income of $28 million. In FY2026, that figure was -$3.7 million, showing that Aehr expects to greatly shift its profitability profile. Using the midpoint of Aehr’s revenue guidance would give it a forward price-to-sales (P/S) ratio of around 20x. That is still a very high figure by most standards, but is down approximately 56% from Aehr’s forward P/S peak of 45x. This shows that the firm's valuation has come much closer to being in line with its revenue expectations. Additionally, after Aehr’s earnings report, analysts at Craig Hallum and Lake Street Capital placed $125 and $110 price targets on the stock, respectively. The average of these figures implies upside near 40%. Aehr clearly remains a highly volatile and risky stock, but that risk is meaningfully lower than it has been over the past several months. Shares remain substantially below highs, and the company just provided consequential data that supports its fundamental outlook. Investors interested in Aehr should closely watch how the company’s orders, guidance, and conversion of backlog into revenue progress going forward. The article "Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth" was originally published by MarketBeat. View MarketBeat's top stocks for July 2026.
Investor releaseQuarter not tagged2026-07-16Aehr Test Systems (AEHR) Beat On Q4 Results, Is The Valuation Gap Too Wide?
Simply Wall St.
Aehr Test Systems (AEHR) Beat On Q4 Results, Is The Valuation Gap Too Wide?
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Aehr Test Systems (AEHR) kicked off its latest earnings season with Q4 2026 results that drew fresh attention to the stock, as investors weighed a quarterly profit against a weaker full year. See our latest analysis for Aehr Test Systems. The earnings surprise has been reflected in Aehr Test Systems’ share price, with a 1-day share price return of 21.91% and 7-day share price return of 29.31%. However, the 30-day share price return is down 24.24%. Over the past year, total shareholder return is very large compared with a 77.39% total shareholder return over three years, suggesting strong long term momentum that has recently cooled and then picked up again around the results. If the post earnings move in Aehr Test Systems has you looking across the chip supply chain, this is a useful moment to scan for other AI exposed opportunities using the 52 AI infrastructure stocks After a 1 day jump and a large 1 year return, Aehr Test Systems still trades about 23% below the average analyst price target. Is that a gap worth closing, or a warning the market is right to leave open? Aehr Test Systems closed at $87.79, while the most followed narrative on the stock suggests a fair value of $18.27, creating a wide valuation gap for investors to unpack. Read the complete narrative. The narrative focuses on how years of dilution, insider selling and expectations for future earnings shape that $18.27 fair value. Curious which revenue path, profit assumptions and valuation multiple sit under that gap versus today’s $87.79 share price? Result: Fair Value of $18.27 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, if Aehr Test Systems delivers steadier profitability or insider activity shifts toward buying or retention, that could challenge parts of this overvaluation narrative. Find out about the key risks to this Aehr Test Systems narrative. If this Aehr Test Systems story feels finely balanced between concern and optimism, consider acting promptly, reviewing the underlying metrics, and weighing both the 2 key rewards and 2 important warning signs. If Aehr Test Systems has sharpened your focus, you can use this momentum to line up a few more quality candidates before the next round of r…Read full documentShow less
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Aehr Test Systems (AEHR) kicked off its latest earnings season with Q4 2026 results that drew fresh attention to the stock, as investors weighed a quarterly profit against a weaker full year. See our latest analysis for Aehr Test Systems. The earnings surprise has been reflected in Aehr Test Systems’ share price, with a 1-day share price return of 21.91% and 7-day share price return of 29.31%. However, the 30-day share price return is down 24.24%. Over the past year, total shareholder return is very large compared with a 77.39% total shareholder return over three years, suggesting strong long term momentum that has recently cooled and then picked up again around the results. If the post earnings move in Aehr Test Systems has you looking across the chip supply chain, this is a useful moment to scan for other AI exposed opportunities using the 52 AI infrastructure stocks After a 1 day jump and a large 1 year return, Aehr Test Systems still trades about 23% below the average analyst price target. Is that a gap worth closing, or a warning the market is right to leave open? Aehr Test Systems closed at $87.79, while the most followed narrative on the stock suggests a fair value of $18.27, creating a wide valuation gap for investors to unpack. Read the complete narrative. The narrative focuses on how years of dilution, insider selling and expectations for future earnings shape that $18.27 fair value. Curious which revenue path, profit assumptions and valuation multiple sit under that gap versus today’s $87.79 share price? Result: Fair Value of $18.27 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, if Aehr Test Systems delivers steadier profitability or insider activity shifts toward buying or retention, that could challenge parts of this overvaluation narrative. Find out about the key risks to this Aehr Test Systems narrative. If this Aehr Test Systems story feels finely balanced between concern and optimism, consider acting promptly, reviewing the underlying metrics, and weighing both the 2 key rewards and 2 important warning signs. If Aehr Test Systems has sharpened your focus, you can use this momentum to line up a few more quality candidates before the next round of results reshapes the opportunity set. Spot potential bargains early by scanning companies that look mispriced on quality and value using the 47 high quality undervalued stocks. Strengthen your watchlist with companies that pair resilient finances and sensible leverage through the solid balance sheet and fundamentals stocks screener (48 results). Hunt for under-the-radar opportunities that combine strong fundamentals with limited attention using the screener containing 20 high quality undiscovered gems. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AEHR. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
Investor releaseQuarter not tagged2026-07-15ASML Stock Rises On Second-Quarter Beat, Raised Forecast
Investor's Business Daily
ASML Stock Rises On Second-Quarter Beat, Raised Forecast
Semiconductor equipment giant ASML beat estimates for the second quarter and raised its outlook for the full year. ASML stock rose on the news.
Investor releaseQuarter not tagged2026-07-15Aehr Test Systems surge on earnings beat, strong guidance
Proactive
Aehr Test Systems surge on earnings beat, strong guidance
Aehr Test Systems (NASDAQ:AEHR) shares jumped 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and provided a stronger-than-anticipated revenue outlook for fiscal 2027. The company posted adjusted earnings of $0.11 per diluted share for the quarter ended May 29, 2026, compared with analyst expectations for a loss of $0.01 per share. Revenue came in at $18.8 million, ahead of consensus estimates of $17.9 million and up from $14.1 million in the year-ago period. On a GAAP basis, Aehr reported net income of $1.4 million, or $0.04 per diluted share, compared with a net loss of $2.9 million, or $0.10 per diluted share, in the fourth quarter of fiscal 2025. Non-GAAP net income, which excludes stock-based compensation and acquisition-related adjustments, was $3.6 million, or $0.11 per diluted share, compared with a non-GAAP loss of $0.2 million, or $0.01 per share, a year earlier. The company also reported record quarterly bookings of $60.7 million, contributing to backlog of $80.6 million as of May 29. Including bookings received after the quarter-end, Aehr’s effective backlog stood at approximately $100.6 million. For the full fiscal year 2026, revenue totaled $50 million, compared with $59 million in fiscal 2025. The company reported a GAAP net loss of $7.1 million, or $0.23 per diluted share, compared with a net loss of $3.9 million, or $0.13 per share, in the prior year. Aehr ended the fiscal year with $116.5 million in cash, cash equivalents and restricted cash, up from $37.1 million at the end of its fiscal third quarter. “We are very pleased with our fiscal fourth quarter performance, which exceeded expectations and capped a year of significant bookings and revenue diversification for Aehr,” Aehr CEO Gayn Erickson said in a statement. “Record quarterly bookings, a very strong backlog, and growing demand across AI processors, silicon photonics, and power semiconductors for our wafer-level and package-level burn-in solutions position us well for significant growth moving forward.” For fiscal 2027, management forecast revenue of between $130 million and $150 million, significantly above analyst expectations of roughly $85 million.
Investor releaseQuarter not tagged2026-07-15Aehr Test Systems (AEHR) Q4 2026 Earnings Call Transcript
Motley Fool
Aehr Test Systems (AEHR) Q4 2026 Earnings Call Transcript
Image source: The Motley Fool. Tuesday, July 14, 2026 at 5:00 p.m. ET President and Chief Executive Officer - Gayn Erickson Chief Financial Officer - Chris Siu Investor Relations - Jim Byers Operator: Good afternoon. Thank you for holding your conference will begin very shortly. Please remain on the line. Your conference will begin in just a couple of minutes. Good day. Welcome to the Aehr Test Systems Fiscal 26 Fourth Quarter and Full Year Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded. I will now turn the conference over to your host, Jim Byers, at Pondel Wilkinson Investor Relations. Jim, you may begin. Jim Byers: Thank you, operator. Good afternoon, and welcome to Aehr Test Systems Fiscal 26 Fourth Quarter and Full Year Financial Results Conference Call. With me on today's call are Aehr Test Systems President and Chief Executive Officer, Gayn Erickson and Chief Financial officer, Chris Siu. Before I turn the call over to Chris and Gayn, I would like to cover a few quick items. This afternoon, right after market close, Aehr Test issued a press release announcing its fiscal 26 fourth quarter and full-year results. That release is available on the company's website at aehr.com. This call is being broadcast live over the Internet. For all interested parties and the webcast will be archived on the Investor Relations page of the company's website. And I would like to remind everyone that on today's call, management will be making forward looking statements. That are based on current information and estimates and are subject to a number of risks and uncertainties, that could cause actual results to differ materially from those in the forward looking statements. These factors are discussed in the company's most recent periodic and current reports filed with the SEC. These forward looking statements, including guidance provided during today's call, are only valid as of this date, and Aehr Test Systems undertakes no obligation to update the forward looking statements. Now with that said, I would like to turn the call over to Gayn Erickson, President and CEO. Gayn Erickson: Thanks, Jim, and good afternoon, everyone, and welcome to our fiscal 2026 fourth quarter and full year earnings conference call. I will start with an updat…Read full documentShow less
Image source: The Motley Fool. Tuesday, July 14, 2026 at 5:00 p.m. ET President and Chief Executive Officer - Gayn Erickson Chief Financial Officer - Chris Siu Investor Relations - Jim Byers Operator: Good afternoon. Thank you for holding your conference will begin very shortly. Please remain on the line. Your conference will begin in just a couple of minutes. Good day. Welcome to the Aehr Test Systems Fiscal 26 Fourth Quarter and Full Year Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded. I will now turn the conference over to your host, Jim Byers, at Pondel Wilkinson Investor Relations. Jim, you may begin. Jim Byers: Thank you, operator. Good afternoon, and welcome to Aehr Test Systems Fiscal 26 Fourth Quarter and Full Year Financial Results Conference Call. With me on today's call are Aehr Test Systems President and Chief Executive Officer, Gayn Erickson and Chief Financial officer, Chris Siu. Before I turn the call over to Chris and Gayn, I would like to cover a few quick items. This afternoon, right after market close, Aehr Test issued a press release announcing its fiscal 26 fourth quarter and full-year results. That release is available on the company's website at aehr.com. This call is being broadcast live over the Internet. For all interested parties and the webcast will be archived on the Investor Relations page of the company's website. And I would like to remind everyone that on today's call, management will be making forward looking statements. That are based on current information and estimates and are subject to a number of risks and uncertainties, that could cause actual results to differ materially from those in the forward looking statements. These factors are discussed in the company's most recent periodic and current reports filed with the SEC. These forward looking statements, including guidance provided during today's call, are only valid as of this date, and Aehr Test Systems undertakes no obligation to update the forward looking statements. Now with that said, I would like to turn the call over to Gayn Erickson, President and CEO. Gayn Erickson: Thanks, Jim, and good afternoon, everyone, and welcome to our fiscal 2026 fourth quarter and full year earnings conference call. I will start with an update on the key markets driving our business, including the strong demand we are seeing in the AI and data center infrastructure markets. As well as the significant progress we made this year in diversifying and expanding our end markets. Chris will then go over our and review our financial results and open up the call for questions. We are very pleased with our fiscal fourth quarter, which exceeded consensus street expectations and capped the year of significant bookings and revenue diversification for Aehr. Record quarterly bookings a very strong and record backlog, and growing demand across AI processors, silicon photonics, and power semiconductors for both our wafer level and package level burn-in solutions positions us well for significant growth in 2027 and moving forward. Fiscal 27 that is. With strong momentum and a record backlog heading into fiscal 2027, we are expecting revenue of between $130 million and $150 million representing 2.6x to 3x the just-completed fiscal 26 revenue. Non GAAP pretax profitability at these levels is expected to come in between 18% to 22%. With current customer forecasts that we are seeing across our wafer level and package level burn in platforms, we see the opportunity to increase our revenue guidance even higher as additional orders materialize. We believe we are not capacity limited even at the $150 million revenue level. To illustrate the progress we have made in diversifying its additional high growth markets. Just 2 years ago, over 95% of our business was tied to silicon carbide for electric vehicles. Whereas today, almost 95% of our fiscal year 2020 revenue came from markets other than electric vehicles silicon carbide. Reliability and production wafer-level burn-in and screening for AI accelerators, CPUs, and network processors were our fastest growing markets this year. Representing approximately 71% of our total annual revenue. Optical device test and burn in for data center infrastructure transceivers chip to chip IO, and hard disk drives accounted for another 20%. We expect both of these markets to grow significantly in fiscal 27 and we are seeing encouraging signs of recovery in the silicon carbide market as well as new growth opportunities. Opportunities for power semiconductors such as in gallium nitride and even silicon based power MOSFETs used in both automotive and AI data center applications. So let me provide an update on several of the key markets and customer initiatives. And I will start with wafer level burn in. Demand from AI related applications continues to accelerate, Our lead AI processor wafer-level burn-in customer is significantly ramping their products driving an increase in forecasted capacity needs for our FOX systems in proprietary WaferPak full wafer contactors this year and over the next few years. This past year, they have ordered our fully automated WaferPak aligners to integrate with their installed base. Doubled their systems from us, and are forecasting significant increases in wafer allocation from their foundry this year and into the future. This had been a challenge to their growth over the last year. We are happy to see them move all production burn in screening to wafer level burn in on our system this past year. They no longer need to perform any system-level screening of their products. This customer sees Aehr as a critical supplier, and we are working to ensure we can meet all their capacity needs as they forecast significant growth in system purchases and WaferPaks this year and over the next few years. In addition, we are engaged with additional AI processor customers who are evaluating wafer level burn in to improve their product reliability and reduce yield loss from production burn-in of their devices later in the manufacturing process. This includes 1 of our largest package-level burn-in customers who is now asking us about a wafer level burn in evaluation for future production of 1 of their AI accelerators and CPUs. This is in parallel with ensuring we can meet their package-level burn-in needs with our Sonoma systems. A key advantage of our proprietary WaferPak contactor technology is its ability to manage individual die temperatures enabling significantly better thermal management than conventional package-level approaches. Our systems can process up to 1/4 of a wafer at a time with as many as 9 wafers tested in parallel, delivering a compelling combination of throughput and cost efficiency. So let me provide an update on our wafer level burn in evaluation with a major supplier of AI accelerators, CPUs, and network processors. We are excited to report that we successfully completed the benchmark testing of our wafer-level burn-in solution on 1 of their processors. Achieving results that exceeded their expectations and, in their words, produced results better than they can get at the package level. This top tier AI processor supplier has now expressed interest in moving to pilot production test validation at their semiconductor contract manufacturer in Taiwan for their current high volume device. Which we just completed the benchmark on. Originally, this benchmark was to evaluate wafer level burn in for their next-generation device. Instead, they indicated that based on the results, they are interested to pull this device in and to consider wafer level burn in on this current device as well. They told us this current device is expected to be ramping and achieve significant volumes over the next year or more. In addition, they also requested that we evaluate a second device in parallel. The potential revenue opportunity from 1 of these devices is significant to Aehr in terms of near and long term revenue streams related to the wafer level burn in systems and proprietary Aehr WaferPak contactors. Turning to wafer level burn in for silicon photonics devices. As we have anticipated for the last year, silicon photonics devices and the need for production burn in are now seeing strong momentum as AI data center architectures increasingly rely on optical I/O and high-speed optical interconnects. Our lead silicon photonics customer is ramping. With follow on orders over the past year and more already in this fiscal year, for fully automated wafer level burn in systems powering AI optical IO data center interconnects. These systems are fully integrated with their automated wafer handling equipment enabling fully automated high volume production burn in with hands free operation using automatic guided vehicles. This marked another important milestone with this long term customer. In addition, our newest major silicon photonics customer, a global leader in networking products and solutions, has provided us with a forecast for additional systems this calendar year as it ramps capacity to support next-generation hyperscale data center deployments. This customer first engaged with us just last November and has since ordered 2 of our 9 wafer FOX test cells and 2 of our FOX NPs. This engagement prod progress progressed quickly from initial contact to their first order and our first delivery of fully integrated test cell. We believe our sales process is shortening over time as our wafer level burn in solutions are becoming more pervasive across multiple industries, customers, and countries. We believe the silicon photonics and optical test and burn in market has substantial growth potential and can be a meaningful long term growth driver for Aehr. So now let me share some highlights of our progress in power semiconductors and wafer-level burn-in, in the past year. We completed more than a dozen designs for gallium nitride WaferPaks which are now being sampled by potential customers. Many, if not all, are expected to move to volume production on our wafer level burn in systems. Driving the need for systems and WaferPaks this year and going forward. We also just completed the world's first 300mm GaN wafer level burn in solution using our high voltage WaferPaks to stress and test the critical high temperature reverse bias test needed to screen for GaN MOSFET defects in production. Just recently, we closed the sale of our first FOX system for a silicon MOSFET wafer level burn in application. Prior to this, customers had purchased our FOX wafer level burn in systems only for nonsilicon MOSFETs, such as silicon carbide and gallium nitride. We are working with this customer to determine test times and quality screening modes that we hope will lead to production burn-in capacity needs as the customer has indicated. We also captured our first silicon carbide customer in Taiwan This customer works closely with several automotive manufacturers in Taiwan and China. In Taiwan and China as well as other international companies. Securing this win was especially important to us because they chose Aehr over Semi, a Chinese company that recently reincorporated in Malaysia as Nexus Test, for their silicon carbide wafer-level burn-in products. As some of you know, Aehr Test is currently suing SemiNexus Test for patent infringement on their silicon carbide focused wafer level burn in system. We believe they are violating our IP and patents that we hold in many countries around the world including China, Taiwan, Japan, Korea, Singapore, the EU, and The United States. We were chosen over Semi due to technical superiority, cost, and our reputation in the automotive industry for production wafer level burn in of silicon carbide devices for EVs. We are seeing encouraging signs of recovery in the silicon carbide power semiconductors, and are actively engaged to meet the wafer level burn in needs of several of the world's largest automotive OEM manufacturers. the car and EV suppliers, And several of their silicon carbide suppliers for their new electric vehicles. We also announced today that we received approximately $8 million in new orders in just the last month for silicon carbide wafer level burn-in and WaferPaks as global electric vehicle programs accelerate. These include expanded production orders from our lead silicon carbide customer for WaferPak full wafer contactors and a key order directly from 1 of the largest automotive companies in the world for multiple WaferPaks to be used in the qualification of silicon carbide devices from suppliers for the new generation of electric vehicles using Aehr's FOX wafer level burn in systems. This year, we expect renewed demand for both silicon carbide and GaN power semi test and burn-in driven by automotive electrification and AI data center. data center power infrastructure. Let me talk a little bit about wafer level burn in for memory. We also continue to pursue opportunities in memory, including NAND flash and potential high bandwidth memory DRAM applications. as part of our wafer-level burn-in solutions roadmap. The growth of these 2 memory markets may be stronger than ever with massive capacity increases planned for this decade. With our wafer level burn in benchmark with a global leader in NAND flash completed, we are in discussions on how to move forward. As we said last quarter, we hope to close on discussions about test system specifications needed for next-generation flash memories. And in particular, their high bandwidth flash devices. Which would lead to a development agreement to supply systems and WaferPaks to them over a 12- to 18-month development and deployment of our new memory-optimized blades, For our FOX XP and MP multi wafer test and burn in platform. We are also in ongoing discussions with other key memory suppliers that produce high bandwidth memory the new DRAM standard used in AI GPUs, as well as standard DRAM and flash memories to align our solutions with the production needs of these companies' new capacity coming online. As we have noted before, this is a key focus for Aehr this year with the goal of reaching an agreement with these customers to develop the enhancements needed to extend our FOX system into these markets. We believe this market could drive orders in fiscal 27 with ramps in fiscal 28. Now turning to package-level burn-in. Our package-level burn-in business for AI processors also gained momentum over the year highlighted by record follow on production orders from our lead hyperscale customer for Sonoma Systems for supporting high volume AI processor production burn-in. This customer is a premier large scale data center provider and is forecasting a substantial expansion of Sonoma system purchases for a second device which is twice the power per package as the first device they are using Sonoma systems for today. As their current and next generation devices ramp, we believe Sonoma systems and consumables can become an increasingly important contributor to Aehr's revenue. This past year, we secured key new device wins on the Sonoma platform. For high-temperature operating life qualification. We are also engaged with multiple current and prospective customers for package-level reliability qualification and production burn-in of AI accelerators, ASICs, network processors, and also for edge AI processors for automotive and robotics. Which represent significant opportunities for Aehr over the next few years. Recently, we introduced an enhanced Sonoma high power configuration designed for next generation CPUs, GPUs, and high-performance network processors used in AI data center and communications applications. This enhanced system expands the Sonoma product family's capabilities with per device power up to 2,000W or more increasing total system power capacity, and improved device counts scalability. It also includes an optional, fully integrated auto-aligner and a high throughput automated loader/unloader that enables completely hands free operation in the production environment. Unlike traditional batch flow burn-in, the Sonoma high power configuration with its ALU is designed for continuous flow operation. Enabling devices to begin testing immediately upon insertion. The automation and thermal systems run continuously, maximizing equipment utilization, throughput, and return on investment for both engineering qualification and high volume manufacturing environments. Our Sonoma systems deliver what we believe is the industry's lowest cost solution enabling customers to transition seamlessly from early reliability characterization to full production burn in and early life failure screening. This approach helps reduce costs, improve quality, and accelerate time to market. To meet anticipated demand, we have been expanding manufacturing capacity for both our systems and consumables. that is both on the wafer level and on the package level. This additional capacity positions us to support expected customer ramp ups and provides flexibility if demand exceeds our current outlook. Looking ahead, we are very excited about our positioning entering fiscal 27 We have multiple customers who began production over the past 12 months and are now ramping up. Creating the potential for meaningful follow on demand for systems and consumables. With multiple customers entering or expanding production, a record backlog, and additional opportunities under discussion for both wafer level and package level burn in we believe we are as well positioned for multiple years of strong revenue growth. With that, I will turn it over to Chris. Chris Siu: Thank you, Gayn. Before I review our financial results, I would like to provide a brief update on the steps we are taking to expand our manufacturing capacity. and consumer support infrastructure to support our growing backlog and future growth opportunities. As Gay mentioned in the last conference call, we continue to scale our manufacturing capacity to support growing demand. In addition to our Fremont expansion, we began shipping Sonoma systems from 1 of our existing contract manufacturers in Southeast Asia. This adds capacity for more than 20 additional Sonoma systems per month. And gives us greater flexibility as we scale to meet customer demand. With the recent record $41 million purchase order we received from our hyperscale customer in April, We are very active operationally as we build Sonoma systems to meet the customer's delivery schedule. This system is expected to be delivered this year to the OSAT of our hyperscale customer. Which is based in Taiwan. Kain also reported today that we successfully completed benchmark testing of our wafer level burn in solution with a major supplier of AI accelerators, CPUs, and network processors. The testing was completed on 1 of their processors, and achieved results that exceeded their expectations. This top tier AI processor supplier has now expressed interest in moving to pilot production test validation for its current high volume device. Anticipation of next stage of this project, we have recently signed a new lease to expand our office in Hsinchu, Taiwan. This expansion will allow us to increase our local sales and customer support personnel deepen our engagement with customers and ecosystem partners in the region. And strengthen our ability to support future production ramps. With recent manufacturing capacity enhancements, and an increased presence in Taiwan, we believe we are well positioned to support significant growth in both wafer level and package level burning systems. As customers ramp production. Now to our financial results. Bookings in the fourth quarter of fiscal 26 were $60.7 million up more than 500% from $11.1 million in the prior year quarter. The increase was primarily driven by purchase orders for Sonoma package level and FOX wafer-level burn-in systems, WaferPaks, and burn-in boards for AI and silicon photonics processor burn in. Partially offset by lower customer orders for silicon carbide wafer packs. Backlog at year-end was a record $80.6 million up from $15.2 million at the end of fiscal 25. Subsequent to year end, we received an additional $20 million in bookings during the 4-week transition period and the first 2 weeks of fiscal 27. As a result, our effective backlog increased to approximately $100.6 million before taking into account minimal shipments during the transition period ended June 26, 2026. Which is not part of fiscal year 27. Turning to our Q4 performance, we are excited about our continued momentum in the artificial intelligence and data center markets. AI processors and silicon photonics burn-in accounted for more than 80% of our fourth quarter revenue. Compared with 56% in the prior year period. For the fourth quarter, we had 3 customers representing more than 10% of total revenue. 2 of these customers target the AI market and the third focuses on the data center optical transceiver market. Revenue for the fourth quarter totaled $18.8 million up 34% from $14.1 million in the prior year quarter. The increase was primarily driven by strong demand from AI and data center customers for our FOX systems, WaferPak Aligners, and WaferPaks. Contactor revenue was $5.8 million representing 31% of our total fourth quarter revenue. Compared with 30% in the prior year quarter. This remains a sizable revenue stream for Aehr driven by demand for new WaferPak designs. As existing and new customers deploy FOX systems for additional device applications. Non-GAAP gross margin for the fourth quarter was 45% up 1 thousand basis points compared with 35% in the same period last year. The increase was primarily due to high revenue levels improved manufacturing capacity utilization, and more favorable product mix. In the fourth quarter of fiscal 25, our revenue was driven primarily by the sale of package level burn in systems, which had lower product margins. Non-GAAP operating expenses in the fourth quarter were $7.5 million compared with $5.4 million in the prior year quarter. The year over year increase was primarily attributable to higher employment costs as we added headcount to support our R&D projects, as well as higher commissions related to record bookings from customers in the AI and data center markets. As an update on our patent litigation against Semi in China we continue to incur legal fees during the fourth quarter to support our claims. We are encouraged that the patent office in the Beijing district of the People's Republic of China has upheld 2 of our Chinese patents. Which is critical to our litigation against Semi. The case is still ongoing and we anticipate incurring additional legal expenses in upcoming quarters. As we continue to protect our intellectual property rights in China. Non-GAAP net income for the fourth quarter, excluding the impact of stock based compensation and amortization of intangible assets, was $3.6 million or $0.11 per diluted share. Well above Street consensus. This compares with a non GAAP net loss of $200 thousand or negative $0.01 per diluted share in the fourth quarter of fiscal 25. Turning to the full year results, we reported revenue of $50 million down 15% year over year. Full-year non-GAAP gross margin was 38.5% compared with 44% in the prior year. Full-year non-GAAP net income was $900 thousand or $0.03 per diluted share. Compared with non GAAP net income of $4.6 million or $0.15 per diluted share in fiscal 25. At the end of the fourth quarter, cash, cash equivalents and restricted cash totaled $116.5 million compared with $26.5 million at the end of fiscal 2025. During fiscal 26, we raised approximately $100 million primarily through our ATM program. Significantly strengthening our balance sheet. Although Aehr remains a capital light company, with only $2.1 million in capital expenditures in fiscal 26, This enhanced financial position provides the working capital and flexibility to pursue larger customer opportunities and scale production to meet customer demand. Now, I will share our guidance. For the fiscal year ending June 25, 2027. We expect total company revenue to be between $130 million and $150 million representing expected year over year growth of approximately 160% to 200%. This outlook is based on the information available to us today. Including our current backlog and anticipated customer demand. We continue to pursue additional orders from existing and prospective customers. We also expect pretax non GAAP net income to be 18% to 22% of total revenues. Lastly, looking at our investor relations calendar. Aehr Test will be participating in 3 upcoming investor conferences. Over the next couple of months. We will meet with investors virtually at the Needham Sixth Annual Semiconductor and Semi-Cap 1 on 1 Conference on Wednesday, August 20. The following week, we will meet with investors in person on Tuesday, August 26, at the Jefferies Technology Summit Conference in Chicago. On September 10, we will meet with investors in person at the Lake Street Capital's Annual Big Ideas Growth Conference in New York City. We hope to see some of you at these conferences. This concludes our prepared remarks. Operator, we are now ready to take questions. Operator: Thank you. At this time, we will be conducting a question and answer session. If you would like to ask a question, please press 1 on your telephone keypad. Confirmation tone will indicate your line is in the question queue. You may press 2 if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. Once again, please press 1 on your phone at this time. if you wish to ask a question. And please hold while we poll for questions. And the first question today is coming from Christian Schwab from Craig Hallum Capital Group. Chris, your line is live. Christian Schwab: Thank you. Congratulations on the fantastic outlook. Gayn, I know you gave some description of revenue by application. For the last fiscal year. But as we are thinking about the $100 million to $150 million, not obviously asking by wafer-level burn-in. Or the Sonoma systems. But can you just give a rough idea of the assumption as far as product mix between AI chips silicon photonics, power, and if there will be any memory revenue, which sounds like that is fiscal 28. Gayn Erickson: So we will. And the only challenge, of course, is we have never done that before. And so in reality, our ability to always predict. But in our current kind of roll-up right now, it is pretty similar to last year. In terms of AI, 70-ish percent The silicon photonics maybe 15% to 20%, maybe in that same range. And then the power semiconductor and miscellaneous, it is kind of the rest. But there is some pretty good and by the way, and I will state, we currently do not anticipate any memory revenue in even the 150 number. So upside on any potential revenue from memory would be in addition to that, but right now, we are not assuming any of that. And the bulk of that if not the majority of all of that range of $130 million to $150 million is coming from current customers. So not really even including I want to give myself a little leeway of this new benchmark customer that we just completed with amazing results. That would be upside to that as well. So you know, I think last year, talked about, the silicon carbide customers a year ago were all talking about how great it is going to be and this is going to be a turnaround year. They did not really give us really detailed forecasts. So I think I shared a year ago. I am kind of in a wait and see mode. I will just believe it when I see the orders. This year seems a little bit more specific. You know, we see some people with real numbers, some real forecasts, some real targets. We are seeing the population of our installed base be at pretty well at full capacity. So it does feel more real this year, and so I am more optimistic. But we still have a pretty small number-- yeah, a pretty small number. I think we might have just exceeded it. So that will that is probably 1 day till Chris is looking at me like I am cheering too much. Alright? So those orders we just got in, I think, exceed what we were already planning. So we will see how this goes. there is just a lot of opportunity, but AI is going to be a big, a big chunk of our business this year. Both in dollars and a percentage. Fantastic. Thanks for that clarity. And then just on the memory, it sounds like you feel more confident in the development program. Last quarter, you did mention kind of roughly the same words that you know, that it could lead to orders in 2027 and revenue in 2028 But it sounded like you were more confident that you will get orders at some point in fiscal 27 for revenue in 2028. Did I hear that right, or did I-- I hope I am more confident than last-- I am not sure I am more confident than last quarter. I mean, I was moderately confident last quarter as well. We have more detail We have actually started to spend money on it. So we have hired some people and redirected some people, and we are doing architectural schematics and assessment. there is some software that started, you know, physical board layouts as part of the proposals to the customers. And, but we really believe you need a committed customer to a project. You know, there is a sort of whether it be a PO or a sponsorship, but you need to make sure you are aligned with what they want and what they are gonna buy at the price point you are willing to sell them at. And that is the piece that we still need to get ourselves resolved. To. there is been some dynamics during the last year. Look in the last 12 months. what is kinda changed The introduction of high bandwidth flash is a doozy. Right? That has really put, at least a couple of them, it is publicly known, on their heels in terms of what they were gonna do, how they could test it, and it broke a lot of things. The other piece is the new HBM, which is a DRAM. Right? High bandwidth memory is DRAM. High bandwidth flash is, of course, flash. But HBM, new standards that are coming out, and I do not wanna get too carried away here, some of which driven by specific end users. Have embedded BIST capabilities in it. Which means that the testability changes dramatically and we think could be in our favor. So it is given me some additional optimism with respect to our ability to maybe do HBM sooner than we were thinking, certainly 6 months ago. But I am gonna just keep a optimistic attitude that we are going after this business, but I would be hesitant for you to build models with a lot of revenue in that yet. Certainly not next year. Great. And then I will just slip in 1 more if I could. There was a lot of different discussions regarding capacity, and I guess I could not write all the answers down quick enough to kind of do the math. But as you sit here today, as far as top line revenue capacity, what do you believe it is? Yeah. So we have talked about some different pinch points. Okay? So people that have visited us know that until recently, all of our systems and our consumable WaferPaks came out of our Fremont facility. But the supply chain of our chambers our blades, and all the subsystems and printed circuit boards are, of course, built by contract manufacturers. For the, 150 employees or thereabouts that Aehr has, We have probably another 250 people in direct contract manufacturers building stuff for us in low cost regions around the world. We have increased our capability in our facility maybe tenfold with the remodel and the other things that we have done. But we still are only running 1 shift from an operational perspective. We do not have the people to ship 10-fold. But the capacity is here to be able to do that. People go, well, that is crazy. Why would you do that? Well, as of the deals we are talking about, if a customer comes to us and said, 'I want 100 systems,' you have to be able to say, 'I can do that, and it will not take me 3 years to build it for you.' Okay? In parallel, we talked about this in more detail last quarter. We pulled the trigger last September with 1 of the contract manufacturers in Asia that does assemblies of 1 of our chamber suppliers. And they upgraded their facility to near clean room space. In anticipation of some of the projects that we wanted to outsource to them. We then initiated and gave them orders and worked with them to build our Sonoma systems. And then the last quarter, we shipped our first Sonoma systems directly to a customer out of that facility. Our team was there working with them, bringing them up, qualifying everything, demonstrating, then observing, then qualifying, the tools. But those systems are actually being installed, I think, last week or this week. At our large hyperscaler customer. And their entire backlog is expected to ship directly out of there. We think the capacity out of that is probably upwards of 20 Sonoma systems a month. And that would basically not impact any of our capacity here. So our capacity is significant, measured in hundreds of millions of dollars for sure. And we are doing some things to even potentially increase that. Not that we would then ship a billion dollars a year, but what happens if we have to ship a couple hundred million in a quarter? Think of it that way. So 1 of the challenges in our business is that it is always going to be lumpy. And do not wanna put money in place and infrastructure that is permanent because, the business is cyclical. And, you know, 5 to 8 years from now, what is this thing look like? We do not want to have built up into a you know, an enormous business. And if there is a softer year that we start losing money or not making as much profit. So I know that is a negative tone on this thing, but the discipline is how do you build up massive amounts of capacity without building up massive amounts of just fixed infrastructure? Got it. that is, fantastically clear. Thanks. No other questions. Chris Siu: Thanks, Chris. Operator: Thank you. Thank you. The next question is coming from Jed Dorsheimer from William Blair. Jed, your line is live. Jed Dorsheimer: Hey, thanks. Thanks for taking my question. And big congratulations to you, Gayn and Chris. I know how long it is been coming in terms of this inflection. So few questions for you. I guess, first 1, maybe just to piggyback off your last response, Gayn, to Chris there. Gayn Erickson: Did I hear you correctly? 20 Sonoma systems per month. And if that is the case, that is about $100 million for Sonoma. Is that the right way to think about that in terms of the $140 million midpoint of guide? So let me make sure I understand. So at our $140 million midpoint, that is nowhere near 20 Sonoma systems a month. The production Sonoma systems that we have in backlog, we have shared this in with different people. Including the consumable elements are somewhere in the, you know, $600 thousand to $700 thousand apiece. They are actually smaller configurations by times quantity. And I think that we have done a pretty good job of announcing orders along the way. So package-level burn-in Sonoma revenues are-- making sure I do this. I have them in front of me right now. probably $50 million something along that range. I think that is good. Larry, guys. I should have it in front of me. So, that is-- think of the math of that, whatever, that 60 to 70 systems or so. So but we are actually shipping those. The customers actually ask for those kind of in a small period of time. You know, very much centered around our second quarter. And so that is gonna be 1 of the challenges. We are actually building them right now. We are gonna start shipping them here during this quarter, and then the bulk of them actually get delivered in the second quarter. That is, that is helpful. And then on the wafer level, if we took that midpoint, what are the are you mixing in? I am trying to separate consumables from package and wafer level. Can you give some framework in terms of that breakdown? Chris Siu: Well, let me answer that question, Jed. So if you heard me, I mentioned about-- we are roughly in the 30%. Contribution. Or-- yeah, wafer packs and-- in revenue. Yeah, in revenue. And that is WaferPaks and BIMs? Yeah. Yeah. And Oh, I think that is a good assumption. Gayn Erickson: it is about 30%. That sounds right to me as well. Yep. Jed Dorsheimer: Okay. that is super helpful. And then 2 more from me. Just, you know, along the lines or maybe 3 more. Larry. But your largest processor -- GPU, TPU, CPU -- customer, your AI customer, I think, is how you describe it. In addition to the benchmark testing, I am just curious, they are going with package level, but could you update on the discussions around wafer-level? Gayn Erickson: I am assuming that they are also engaged in kind of-- yeah. You know, that, that opened the door if you will. So, just an update on that. it is a bit of a lookup table. So we when I think what you are talking about is our lead AI production package-level burn-in customer, Who we have identified as 1 of the big hyperscalers. Okay? Alright. They use Sonoma for all their qualification. They had never done production burn-in before, and they moved to production burn-in as we acquired InCal. And that is been a great win for everybody because of our capabilities to support them and, obviously, to meet their capacity needs. That customer the first device that ever went to production was on Sonoma. The second device is also going to be on Sonoma. They already bought some of the systems for it. That particular device has been a little bit delayed in terms of its timing, but it is still expected to ramp, or at least start the ramp during our fiscal year at this point. that is the 1 I described that has twice the power, and they are expecting higher volumes off of it. Right? And then that same customer talked to us, what, maybe 6 months ago, first time. The third device they really wanna consider wafer-level burn-in. And 1 way you might wanna think about it is if there is a progression of number of compute in a single package, as they get higher, wafer-level burn-in has a huge advantage because the devices fail during burn in, and if you fail 1 of the compute chips, you throw away the other compute chips and all of the memory. And so at that point, it gets extremely, expensive from a yield loss to continue to do package-level burn-in. So that would be where you would wanna cut in that wafer-level burn-in. So they have actually recently, again, this quarter, you know, again, they are just bringing up their second device, but the third 1, been talking to us about, okay. What DFT do we need to do? What do we need to put in? How do we optimize it around the Fox system? So it is pretty encouraging. Got it. that is helpful. And just shifting gears, silicon photonics and copackaged optics, I know you mentioned activities. The gallium nitride really had struggled with reliability in that, in the auto. Auto requirements are far lower than in data center. by about 5x, in terms of mean time to failure. So, I think that would be a good thing for you guys, but I am just curious how you are thinking about market adoption, timing, and then your role in GaN specifically. I know what you have got for silicon carbide. Just curious in terms of activity around GaN and the higher failure rates there. Chris Siu: Okay. Gayn Erickson: You actually mentioned silicon photonics. You mentioned silicon carbide, and GaN. Let me just think through that window. GaN has been interesting. If you remember a year and a half ago or so when we were in discussions with the first GaN customer, we did not know if they were gonna go to production burn-in or not. Since then, we have been able to verify they are, and they are going to a major qualification with a bunch of industrial automotive, and infrastructure, and data center applications. it is unlike Silicon Carbide that is, like, 2 or 3 big applications. GaN, we have done like 12 different types of devices. So they are, like, different voltages and power and requirements that they go through all, you know, from solar to data center to electric switches in infrastructure and homes. To automotive. They are all over the place. So they all have different kind of requirements, But so far as we can tell, every 1 of them needs a production burn in screening to meet the reliability requirements. And it is been a learning process for us. Silicon GaN is extremely difficult to actually test and burn in at wafer level. We have learned, but it is now been debugged and fully working through, and things are going really well for us right now. So we think that will grow. Now the GaN market, by the forecasters is you know, just dollar wise is measured in, you know, single to tens of billions of dollars over this decade. Whereas, you know, AI or memory is 10x that. So they can just they simply could never spend as much money as some of the other markets. From a reliability perspective, it is very clear the value of burn-in, and we have been proving and validating the value of wafer-level burn-in of GaN similar to silicon carbide. And then silicon photonics similarly, that is been the big debate is as the data centers really need to go to burn-in or to silicon photonics, you know, optical transceivers for fiber optic communication, basically. The burn in requirements are kind of very clear in front and center. So the hyperscalers, the big data center guys are all talking about this, and it is, you know, sort of cool to be in burn-in, if you will, right now. That sounds kind of funny, a play on words. I have actually Chris is laughing. I have never said that before. But it is. it is just right now it is a lot of people are talking about burn in as the kind of the place. I believe that burn-in is by far the fastest growing segment in all of semiconductor test right now. And wafer level burn in particular. Awesome. Jed Dorsheimer: Last question for me. I promise. Chris, can you just help with cadence in terms of as you look at the year? How are you thinking? I mean, Gayn mentioned second quarter in terms of some concentration on the package level burn in systems. Is there some way to think about there is a pretty big shift year over year in terms of the uplift, how to think about that flow as we go through the year. Any thoughts there? Or, not specific guidance but just general seasonality or run-rate kind of thing. Exactly. Chris Siu: So if you know historically, we kind of said, hey. Our first half is softer than the second half. But I would say this year, it is hard to say that because as Gayn mentioned, we are going to ship a lot of the package level Sonoma systems in the second quarter. Right. So, second quarter is going to be a big quarter. Gayn Erickson: So First part is looking pretty good. Yeah. Pretty good. Gonna be bigger. Maybe third quarter is flattish than fourth quarter is up from there. Chris Siu: So there is a high likelihood that the first half might be the same or even better than the second half, but second quarter is gonna be a good very strong quarter for us. Jed Dorsheimer: Got it. I will jump back in queue. Thanks, guys. Gayn Erickson: Alright. Chris Siu: Thank you. Thanks, Jed. Operator: Thank you. Once again, as a reminder, if you have any questions please press 1 on your phone at any time. Next question is coming from Maxwell Michaelis from Lake Street Capital Markets. Maxwell, your line is live. Maxwell Michaelis: Hey, guys. Few questions for me. 1 is a clarification question. So that April order you put out, I think it was a $41 million production follow-on order with the lead hyperscaler. I think that was a production order for the Sonoma systems Just to be clear, that they are not transferring over to wafer-level burn-in. This is a completely different customer. Correct? Gayn Erickson: Oh, that is the 1 we are talking about that is currently on package. Then the second part is package, and the third part is wafer-level or potentially being evaluated for wafer level. It gets kind of interesting because they wanna make sure we can also do the package for the third 1. So we have to you know, we kind of-- I guess we have 2 dogs in that race, and it is a 2 dog race. So Yeah. Okay. But by the way, that third device we think is not even this fiscal year. Okay. I guess kind of my follow-up to that would you expect sort of a similar order size, I mean, for the on the wafer level side for them. Maxwell Michaelis: Good question. Gayn Erickson: If they do the same capacity, it would be higher. Our wafer level systems do in fact cost more per die than the package level today. Margins are better too, but the value proposition is different because you get the yield advantage which more than makes up for the price of the machine. So just from a product positioning and a price-- I mean, we have a lot more IP in it. there is a lot more R&D people. We have enormous investments. We recover through the wafer level. And we have all this IP that is worth it. So customers come to us not just to cost-effectively do burn-in, but at wafer level, it is because the device does not even exist in another form, or they put the device in with something else, and then if they burn it in and it fails, then the something else gets thrown away. And so the wafer level burn in value proposition has more to do with the yield improvement which can be measured in you know, 1% of all products if they have you know, 8 devices in a package, it is equivalent of 8% yield advantage. The cost to test might be 0.1% or 0.01%. So the price does not really come into effect. Maxwell Michaelis: Okay. And then last 1 for me, and I do not know. I you might have mentioned it, but that second a major AI processor, that just completed the benchmark testing, I mean, what is sort of the ramp up there? I mean, I mean, I know you kind of left it open-ended with the guidance range of being a $130 million to a $150 million Could you take it higher? I mean, could you see a major order come in fiscal year 2027 be able to complete that? Gayn Erickson: Yes. Pretty brief. Yeah, we can. I mean, as we have been adding capacity and, you know, we have multiple AI customers that are engaged with. To some extent, we can build to forecast. We are having discussions about what if you throw a party and everybody comes. Right? What does that look like? And we are trying to meet at very high levels with the customers and potential customers and make sure we get an idea of what kind of capacity they look like. These systems have a lot of capacity, though. I mean, when you think about a tester that in the same footprint of a competitive ATE machine, like a 93K from Advantest, I am testing, you know, 9 AI wafers in parallel I would say a quarter of the 60 devices that are in that are running. there is a lot of capacity. that you put in place. So if we say, oh, I am gonna go ship 20 machines, right? it is 180 blades. 1 hundred 80 wafers of capacity. A 180-wafer test floor is a big test floor. And we could put 18. you know, we put 20 of these and it is in the size of 20 parking stalls in the garage out in your parking lot. Think of 20 cars out there that is more than enough to support 20 of our machines. Now think of 180 of our competitors in the same garage. And these are state of the art clean room space. These are bunny suited test floors. Awesome. And I have to remember that when someone says, oh, you can ship, you know, 5 XPs a month. You know, if there are 18-blade machines, that is 100 testers a month of capacity. And, like, in silicon carbide, testing all 3 thousand die in parallel in 1 insertion. Per wafer. These are very high volume, very capable machines. it is why we get several million dollars apiece for them. Upwards of 6 including wafer packs. Okay? Maxwell Michaelis: Oh, we lost you, Maxwell. Good for now. Thanks. Okay. Operator: Thank you, Maxwell. Thank you. The next question is coming from Larry Chlebina from Chlebina Capital. Larry, your line is live. Larry Chlebina: Hi, Gayn. I just wanna quantify the capacity in Fremont. You mentioned 1 shift, 2 shifts. So on the Sonoma side that what I call Sonoma-Max, I guess those are fully automated What is the throughput capacity expected on the in Fremont? Gayn Erickson: Is it still 20 Sonoma-Maxes per month? So if you were to come and look at our if you were to come and look at our facility, as many shareholders have, 1 of the what we did in our big modification upgrade a couple years ago was add enormous amount of additional cooling and power capacity. That gives us drop locations for upwards of potentially 16 physical locations for the equipment to be plugged in, another 4 mechanically. Plus the test labs. What does that mean? That means that theoretically, you could have 16 of these machines plugged in and be powered up and going through different levels of test. Now the depending on the tool, they could take from, you know, several days to several weeks to be on that floor. What we have been doing in parallel is bringing up the CMs to be doing most of that work so that when it comes into the facility, maybe they only sit there for 1 week. So if you do that math, you are like, well, wait a minute. You could do 16 a week and 4 per week. Wow. that is a lot. What I have shared with people is, you know, we can reasonably see the ability to do say, 20 combination of package or wafer level systems a month out of this facility within the supply chain infrastructure that we have But we have not initiated all of that. But in certain cases, we have. Like chambers. We have been talking to the CMs about auto aligners. At for both the package and also the wafer level. And so you know, if those were, say, million-dollar Sonoma-Maxes as you call them, we actually call them Ultras. Okay? it is $20 million a month of Sonomas. If you were 20 wafer-level burn-in systems a month, they have an ASP closer with the WaferPaks, $5 million. They are $100 million a month. So people are like, oh my gosh. You have a billion dollars' worth of capacity Conceptually, yes. So for my employees that are listening, we need to hire more people, and there is a lot more work that needs to be done. But with a running head start and a customer forecast, we could do enormous amounts relative to our current size just out of this facility. So actually, the number would be 20 Sonoma Ultras per month or 20 XPs per month, not both, not 20 each. Yeah. Okay. Larry Chlebina: So you are right. Gayn Erickson: You caught me on something. Except we just initiated the 20 Sonomas outside of our facility. No. I know. I know about that. But I know about that. But what it means, Larry, is we could run the 20 Ultras shipping directly from Southeast Asia. And then still do 20 XPs here. A month. Larry Chlebina: Okay. Alright. Gayn Erickson: So, and by the way, I need to put some disclaimers for all the attorneys listening. Know, some of these challenges would be they are, you know, particular material or getting access to some of the challenges that we have seen on the power supplies, for example, on Sonomas is that some of the power Supply Manufacturers That We Use In Sonoma are supplying to NVIDIA and others. And they have come back, they have raised their prices 40%. If you wanna get them. And so we have been buying components with long lead time items and things like that. So you know, if we make it sound easy that we are overstating, it is actually quite difficult to do what we are doing right now. But so far, we are able to keep ahead And then I think almost everything in my backlog we could ship before the customer has requested it. I am thinking, like, all the Sonomas, Chris, you know, all my silicon photonics customers, So far, we have been on top of that, and our goal is to stay ahead of that. So customers, if they want it, we could ship it within the-- as soon as they would like it. Okay. Larry Chlebina: Then on the paid evaluator, did you say that in your guide for the full year, you do not really have any revenues in there from this particular potential customer? Is that did you say that-- call it little to none. You know, at this point. You know, it is in the noise level. So that is potential big upside, assuming that gets kicked off. And then lastly, in your written release, you mentioned on the memory side that, you work with you are working with multiple memory suppliers. Does that mean more than 1 HBM? I mean, how far are you engaged with the HBM potential customers? Gayn Erickson: You have had specific conversations with suppliers. Okay. Let me make sure I do this right. 2 to 3 on Flash and 2 on DRAM. Okay. And the and the primary for that are listening that are not aware, there is literally, like, 4 memory manufacturers in the whole world that matter, so apologize. So and if you are not if for those that are in the 5th and 6th, they might be offended by that. But of the top ones, I am listing it from those. Larry Chlebina: Okay. And then the primary flash you engaged them over 2 years ago. And yet they have any revenue or orders from them? Is that nothing gonna happen there unless HBF gets kicked off? Or as far as you can see or I do not know. Gayn Erickson: You know, that was a huge change amongst some other organizational things that happened to them pretty dramatically about a year and a few months ago. So at this point, feedback recently has been, you know, they really need something for the HBF, but they really want something for their standard flash. HBF architecturally is way more power, more power supplies. it is technically a more expensive tester. But they really like the price point of the current test capability, and so we are kinda working through that. We got to find the math for that. And you know, we need their help to sort of get the ball going because, you know, we obviously have a lot of opportunities ahead. In all kinds of markets, and we would just as soon have them sort of help us help them. Larry Chlebina: Yep. But on a memory side, that would still be the first potential sale revenue for any of the 4 memory people you are talking to. Gayn Erickson: They would be-- I think so, Larry. I am going to-- I would put some bet on a wild card. Larry Chlebina: Because this new HBM has a logic interface, for its testability. Mm-hmm. it is breaking the memory testers. And technically, when I describe a new memory tester, I am talking about well, most people do not know or care on this call, what a memory tester is, but a memory tester is built with pattern generations, it is sort of a different architecture and a different beast than a logic machine. So if you have an APG based memory tester, it would be really good for flash or DRAM. But if you had a logic BIST engine in the device, then it may not even be very good at doing BIST And so you would need something that looks like a logic tester, which candidly is more like what we build today with Flash. The FOX-XP was originally designed for the BIST engine of a couple of the big flash memory manufacturers. Flash has built in self test. DRAM until recently never has. You mentioned that they were coming to you, these HBM potential customers. Would that be a function of potentially this paid evaluator telling them, hey, get over to Airtest and get your reliability better before you take out our accelerators. Gayn Erickson: Is there any angle on that? Do you think that could be-- that would be a little too bold for me right now. I do not think that is the case. Chris Siu: I do think there is a general tone amongst and growing amongst the data center buyers, all the hyperscalers, you know, from Google and Meta, all the papers that you see you know, Apple, certainly Tesla, of an ex an increasing expectation of test and reliability to screen out defects so that does not show up on my data center floor. Gayn Erickson: So that is more of a go get your act together in general than necessarily go to Aehr. I will say that by contrast to the automotive guys, we specifically have automotive EV suppliers telling their suppliers go get Aehr. Okay? I mean, that is true. Right? So that is a different I mean, we love that. Right? But you know, imagine that 1 of the biggest you know, 1 or 2 biggest automotive suppliers in the world buys our WaferPaks tells their suppliers, we would like to qualify you for your silicon carbide reliability, and we are gonna use the Aehr Test FOX system with our WaferPaks to validate your devices. And good luck to you. Pretty impactful. Right? Yep. So I do not have that with the AI customers today. That would be nice, but we do not have that. So yet. Chris Siu: Yeah. Christian, not yet. Good job. Larry Chlebina: Hey, I will let you go. Thank you. Thanks, Larry. Operator: Thank you, Larry. Thank you. I am not seeing any other questions in queue at this time. I will now turn the call back to management for closing remarks. Gayn Erickson: Alright. Well, thank you, everybody, for listening in and joining us. We are really excited to work hard for you guys this year. This is gonna be a great year for Aehr and hopefully for our customers and our shareholders as well. And we look forward to giving you guys an update as we go along. Take care. Operator: Thank you. This does conclude today's conference. You may disconnect your lines at this time. Thank you for your participation. Before you buy stock in Aehr Test Systems, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Aehr Test Systems wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $398,160!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,249,202!* Now, it’s worth noting Stock Advisor’s total average return is 918% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of July 14, 2026. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Aehr Test Systems (AEHR) Q4 2026 Earnings Call Transcript was originally published by The Motley Fool
Investor releaseQuarter not tagged2026-07-15AEHR Stock Skyrockets After Q2 Earnings Beat-and-Raise
Barchart
AEHR Stock Skyrockets After Q2 Earnings Beat-and-Raise
Aehr Test Systems (AEHR) stock pushed higher after the semiconductor equipment manufacturer delivered a remarkable Q4 earnings report on Tuesday evening. The company reported adjusted earnings of $0.11 per share, dramatically surpassing the consensus estimate for a loss of $0.01, while revenue of $18.84 million exceeded the $18.69 million forecast and represented a 34% year-over-year increase from $14.09 million. Nvidia Stock Could Still Soar 140% to Reach $500, Says Wall Street MU Stock Alert: What to Watch as Micron Takes a Stake in GlobalWafers IBM Stock Just Suffered a Gruesome Massacre, But Algos Likely Sense a Huge Discount Here Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Including the post-earnings rally, AEHR shares are trading at more than 4x their price at the start of this year. The most compelling aspect of the report was not the quarterly beat itself but the extraordinary forward guidance. Management issued fiscal 2027 revenue guidance of $140 million, representing growth of about 180% over last year’s revenue of $50 million and crushing the consensus estimate of roughly $85 million. The company also projected non-GAAP pretax net income margins of 18% to 22% of total revenue for fiscal 2027. Record quarterly bookings of $60.7 million — up more than 500% from $11.1 million in the prior-year quarter — underpinned the bullish outlook. The backlog hit a record $80.6 million as of May 29, and the effective backlog, including bookings received after that date, climbed to $100.6 million. This level of visibility into future revenue provides substantial credibility to what otherwise might appear to be an overly ambitious guidance range. Aehr Test Systems has undergone a dramatic transformation in its revenue mix. Two years ago, over 95% of the company’s business was tied to silicon carbide testing for electric vehicles (EVs), whereas nearly 95% of fiscal 2026 revenue came from markets outside EV silicon carbide. Artificial intelligence (AI) processors, CPUs, and network processors now represent roughly 71% of annual revenue, with silicon photonics and data center infrastructure applications accounting for about 20%. AI and silicon photonics burn-in made up more than 80% of fourth-quarter revenue specifically. Management highlighted that its lead AI wafer-level customer ha…Read full documentShow less
Aehr Test Systems (AEHR) stock pushed higher after the semiconductor equipment manufacturer delivered a remarkable Q4 earnings report on Tuesday evening. The company reported adjusted earnings of $0.11 per share, dramatically surpassing the consensus estimate for a loss of $0.01, while revenue of $18.84 million exceeded the $18.69 million forecast and represented a 34% year-over-year increase from $14.09 million. Nvidia Stock Could Still Soar 140% to Reach $500, Says Wall Street MU Stock Alert: What to Watch as Micron Takes a Stake in GlobalWafers IBM Stock Just Suffered a Gruesome Massacre, But Algos Likely Sense a Huge Discount Here Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Including the post-earnings rally, AEHR shares are trading at more than 4x their price at the start of this year. The most compelling aspect of the report was not the quarterly beat itself but the extraordinary forward guidance. Management issued fiscal 2027 revenue guidance of $140 million, representing growth of about 180% over last year’s revenue of $50 million and crushing the consensus estimate of roughly $85 million. The company also projected non-GAAP pretax net income margins of 18% to 22% of total revenue for fiscal 2027. Record quarterly bookings of $60.7 million — up more than 500% from $11.1 million in the prior-year quarter — underpinned the bullish outlook. The backlog hit a record $80.6 million as of May 29, and the effective backlog, including bookings received after that date, climbed to $100.6 million. This level of visibility into future revenue provides substantial credibility to what otherwise might appear to be an overly ambitious guidance range. Aehr Test Systems has undergone a dramatic transformation in its revenue mix. Two years ago, over 95% of the company’s business was tied to silicon carbide testing for electric vehicles (EVs), whereas nearly 95% of fiscal 2026 revenue came from markets outside EV silicon carbide. Artificial intelligence (AI) processors, CPUs, and network processors now represent roughly 71% of annual revenue, with silicon photonics and data center infrastructure applications accounting for about 20%. AI and silicon photonics burn-in made up more than 80% of fourth-quarter revenue specifically. Management highlighted that its lead AI wafer-level customer has moved all production burn-in screening to wafer level on Aehr systems and is forecasting higher capacity needs. AEHR also completed a benchmark test with a key supplier of AI accelerators, CPUs, and network processors, producing results that exceeded customer expectations. In package-level burn-in, the lead hyperscale customer is expanding Sonoma system purchases for a second device with twice the power of the first. From a financial health perspective, Aehr Test Systems ended Q4 with $116.5 million in cash and equivalents, up sharply from $37.1 million at the end of the previous quarter and $26.5 million at the end of fiscal 2025. Non-GAAP gross margin improved to 45% in the fourth quarter — up 1,000 basis points from 35% in the year-ago period — suggesting strong operating leverage as volumes scale. The full fiscal year was more modest, with revenue of $50 million representing a 15% decline year-over-year and full-year non-GAAP net income of just $0.9 million. That said, Wall Street currently sees AEHR stock as overvalued. While the consensus rating on the firm remains at “Moderate Buy,” the mean price objective of about $71 signals significant downside from here. This article was created with the support of automated content tools from our partners at Sigma.AI. Together, our financial data and AI solutions help us to deliver more informed market headline analysis to readers faster than ever. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Investor releaseQuarter not tagged2026-07-15Aehr Test Systems' Q4 Earnings Beat Estimates, Revenues Up Y/Y
Zacks
Aehr Test Systems' Q4 Earnings Beat Estimates, Revenues Up Y/Y
Aehr Test Systems AEHR reported non-GAAP earnings of 11 cents per share for the fourth quarter of fiscal 2026, surpassing the Zacks Consensus Estimate by 1200%. The company had posted a loss of 1 cent per share in the year-ago quarter.Revenues increased 33.7% year over year to $18.84 million and beat the consensus mark by 0.72%. Higher artificial intelligence (AI) and data-center demand, improved manufacturing utilization and favorable product mix supported profitability. Quarterly bookings reached a record $60.7 million. AI processors and silicon photonics burn-in generated more than 80% of fiscal fourth-quarter revenues, up from 56% in the prior-year period. Demand was particularly strong for FOX systems, serial AutoAligners and proprietary WaferPak contactors.Three customers each accounted for more than 10% of quarterly revenues. Two served the AI market, while the third focused on optical transceivers used in data centers. Contactor revenues totaled $5.8 million, representing 31% of the company’s top line compared with 30% a year earlier. Aehr Test Systems price-consensus-eps-surprise-chart | Aehr Test Systems Quote Non-GAAP gross margin expanded to 45% from 35% in the year-ago quarter. The 1,000-basis-point improvement reflected higher revenues, better manufacturing capacity utilization and a more favorable product mix.Non-GAAP operating expenses increased to $7.5 million from $5.4 million. The rise primarily reflected higher employment costs tied to research and development hiring, along with increased commissions associated with strong AI and data center bookings and legal expenses associated with patent litigation in China. Quarterly bookings surged more than 500% year over year to $60.7 million from $11.1 million. Growth was driven by orders for Sonoma package-level systems, FOX wafer-level systems, WaferPaks and burn-in module boards supporting AI and silicon photonics applications.Backlog at fiscal year-end reached $80.6 million, up from $15.2 million a year earlier. AEHR received another $20 million in bookings shortly after year-end, lifting effective backlog to approximately $100.6 million and providing substantial visibility into fiscal 2027 revenues. The lead AI wafer-level burn-in customer doubled its system base during fiscal 2026 and shifted all production burn-in screening from system-level to wafer-level testing. Management expects furth…Read full documentShow less
Aehr Test Systems AEHR reported non-GAAP earnings of 11 cents per share for the fourth quarter of fiscal 2026, surpassing the Zacks Consensus Estimate by 1200%. The company had posted a loss of 1 cent per share in the year-ago quarter.Revenues increased 33.7% year over year to $18.84 million and beat the consensus mark by 0.72%. Higher artificial intelligence (AI) and data-center demand, improved manufacturing utilization and favorable product mix supported profitability. Quarterly bookings reached a record $60.7 million. AI processors and silicon photonics burn-in generated more than 80% of fiscal fourth-quarter revenues, up from 56% in the prior-year period. Demand was particularly strong for FOX systems, serial AutoAligners and proprietary WaferPak contactors.Three customers each accounted for more than 10% of quarterly revenues. Two served the AI market, while the third focused on optical transceivers used in data centers. Contactor revenues totaled $5.8 million, representing 31% of the company’s top line compared with 30% a year earlier. Aehr Test Systems price-consensus-eps-surprise-chart | Aehr Test Systems Quote Non-GAAP gross margin expanded to 45% from 35% in the year-ago quarter. The 1,000-basis-point improvement reflected higher revenues, better manufacturing capacity utilization and a more favorable product mix.Non-GAAP operating expenses increased to $7.5 million from $5.4 million. The rise primarily reflected higher employment costs tied to research and development hiring, along with increased commissions associated with strong AI and data center bookings and legal expenses associated with patent litigation in China. Quarterly bookings surged more than 500% year over year to $60.7 million from $11.1 million. Growth was driven by orders for Sonoma package-level systems, FOX wafer-level systems, WaferPaks and burn-in module boards supporting AI and silicon photonics applications.Backlog at fiscal year-end reached $80.6 million, up from $15.2 million a year earlier. AEHR received another $20 million in bookings shortly after year-end, lifting effective backlog to approximately $100.6 million and providing substantial visibility into fiscal 2027 revenues. The lead AI wafer-level burn-in customer doubled its system base during fiscal 2026 and shifted all production burn-in screening from system-level to wafer-level testing. Management expects further capacity requirements as the customer receives increased wafer allocations from its foundry.AEHR completed benchmark testing with a major supplier of AI accelerators, CPUs and network processors. Results exceeded the customer’s expectations, prompting discussions about pilot production validation for a current high-volume processor and an evaluation of a second device. Revenues from this opportunity are largely excluded from the fiscal 2027 outlook. Silicon photonics demand strengthened as data-center architectures increasingly adopted optical input-output and high-speed interconnect technologies. AEHR’s lead customer placed follow-on orders, while another networking customer provided forecasts for additional systems as it expands capacity for hyperscale deployments.Power semiconductor activity also improved. The company received approximately $8 million in recent silicon carbide WaferPak orders and completed more than a dozen gallium nitride designs. AEHR sold its first FOX system for a silicon MOSFET wafer-level burn-in application. The company began shipping Sonoma systems from a contract manufacturer in Southeast Asia, adding capacity for more than 20 systems per month. AEHR is expanding its Taiwan operations to support customer engagement and potential production ramps.Management highlighted that existing manufacturing capacity can support revenues above the top end of its current guidance. The company expects a significant concentration of Sonoma shipments in the second quarter of fiscal 2027, making that period a particularly strong contributor to the annual revenue profile. As of May 29, 2026, cash, cash equivalents and restricted cash totaled $116.5 million compared with $37.1 million as of Feb. 27, 2026.The company raised approximately $100 million during fiscal 2026, primarily through its at-the-market equity program.Operating activities used $3.3 million in cash in the reported quarter, while capital expenditures totaled $2.1 million. For fiscal 2027, AEHR expects revenues between $130 million and $150 million, implying growth of approximately 160% to 200% from fiscal 2026 revenues of $50 million. Management expects AI-related applications to contribute roughly 70% of revenues, with silicon photonics representing about 15% to 20%.Non-GAAP pretax net income is projected to be 18% to 22% of revenues. Currently, Aehr Test Systems carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the broader Zacks Computer and Technology sector include ASE Technology ASX, Bandwidth BAND and Fortinet FTNT, each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Shares of ASE Technology have gained 150.7% in the year-to-date period. ASX is set to report its second-quarter 2026 results on July 30. Shares of Bandwidth have surged 390.4% in the year-to-date period. BAND is slated to report its second-quarter 2026 results on July 29. Fortinet shares have gained 110.1% in the year-to-date period. FTNT is set to report its second-quarter 2026 results on July 29. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aehr Test Systems (AEHR) : Free Stock Analysis Report Fortinet, Inc. (FTNT) : Free Stock Analysis Report ASE Technology Holding Co., Ltd. (ASX) : Free Stock Analysis Report Bandwidth Inc. (BAND) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research
Investor releaseQuarter not tagged2026-07-15Aehr Test (AEHR) Soars as Bullish Outlook Overshadows Weak FY Earnings
Insider Monkey
Aehr Test (AEHR) Soars as Bullish Outlook Overshadows Weak FY Earnings
Aehr Test Systems climbed by 21.91 percent on Wednesday to close at $87.79 apiece, after management projected a sharp acceleration in its full-year growth for fiscal 2027, underpinned by a record backlog and the continued strong demand for semiconductor testing solutions in AI infrastructure. In an earnings call on Tuesday, the company said that it was optimistic about growing its revenues by 160 percent to 200 percent to a range of $130 million to $150 million, versus the $50 million last year. For illustration purposes only. Photo from Pixabay/Pexels The guidance was supported by an effective backlog of $100 million, providing investors with greater visibility into future revenues. The aggressive outlook helped investors look beyond the company’s weak earnings performance in the full fiscal year 2026, betting that its backlog and increasing AI exposure could mark the beginning of a new growth cycle. Aehr Test Systems (NASDAQ:AEHR) said that its net loss went 82 percent deeper during the period, ending at $7.1 million versus the $3.9 million last year. Revenues were also lower by 15 percent at $50 million versus $59 million year-on-year. However, the company swung to a net profit of $1.4 million in the fourth quarter of fiscal year 2026 from a net loss of $2.9 million in the same period last year, as revenues surged by 33 percent to $18.8 million from $14.1 million year-on-year. Bookings finished at a record of $60.7 million, while backlogs ended at $80.6 million. Effective backlog, including bookings since May 29, was at $100.6 million. Aehr Test Systems (NASDAQ:AEHR) President and CEO Gayn Erickson said that they were pleased with the results, “which exceeded expectations and capped a year of significant bookings and revenue diversification for Aehr.” “[Our] record quarterly bookings, a very strong backlog, and growing demand across AI processors, silicon photonics, and power semiconductors for our wafer-level and package-level burn-in solutions position us well for significant growth moving forward,” he said. More institutional investors are buying into shares of Aehr Test Systems (NASDAQ:AEHR). Based on Insider Monkey’s database, 25 hedge funds held positions in the company as of the end of the first quarter of the year, up from 17 in the quarter prior. Collectively, those funds own approximately $60.9 million worth of stake in the company, signaling th…Read full documentShow less
Aehr Test Systems climbed by 21.91 percent on Wednesday to close at $87.79 apiece, after management projected a sharp acceleration in its full-year growth for fiscal 2027, underpinned by a record backlog and the continued strong demand for semiconductor testing solutions in AI infrastructure. In an earnings call on Tuesday, the company said that it was optimistic about growing its revenues by 160 percent to 200 percent to a range of $130 million to $150 million, versus the $50 million last year. For illustration purposes only. Photo from Pixabay/Pexels The guidance was supported by an effective backlog of $100 million, providing investors with greater visibility into future revenues. The aggressive outlook helped investors look beyond the company’s weak earnings performance in the full fiscal year 2026, betting that its backlog and increasing AI exposure could mark the beginning of a new growth cycle. Aehr Test Systems (NASDAQ:AEHR) said that its net loss went 82 percent deeper during the period, ending at $7.1 million versus the $3.9 million last year. Revenues were also lower by 15 percent at $50 million versus $59 million year-on-year. However, the company swung to a net profit of $1.4 million in the fourth quarter of fiscal year 2026 from a net loss of $2.9 million in the same period last year, as revenues surged by 33 percent to $18.8 million from $14.1 million year-on-year. Bookings finished at a record of $60.7 million, while backlogs ended at $80.6 million. Effective backlog, including bookings since May 29, was at $100.6 million. Aehr Test Systems (NASDAQ:AEHR) President and CEO Gayn Erickson said that they were pleased with the results, “which exceeded expectations and capped a year of significant bookings and revenue diversification for Aehr.” “[Our] record quarterly bookings, a very strong backlog, and growing demand across AI processors, silicon photonics, and power semiconductors for our wafer-level and package-level burn-in solutions position us well for significant growth moving forward,” he said. More institutional investors are buying into shares of Aehr Test Systems (NASDAQ:AEHR). Based on Insider Monkey’s database, 25 hedge funds held positions in the company as of the end of the first quarter of the year, up from 17 in the quarter prior. Collectively, those funds own approximately $60.9 million worth of stake in the company, signaling that professional investors have been increasing their exposure ahead of what management expects to be a significant recovery. While we acknowledge the potential of AEHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News.
Investor releaseQuarter not tagged2026-07-15AEHR Q4 Earnings Call Points to AI-Fueled 2027 Ramp
Zacks
AEHR Q4 Earnings Call Points to AI-Fueled 2027 Ramp
Aehr Test Systems, Inc. AEHR used its fourth-quarter 2026 call to focus less on the quarter itself and more on the scale of demand it sees building into fiscal 2027. Management tied that outlook to AI processors, silicon photonics and a record-effective backlog.The company still posted a headline beat, with adjusted EPS of 11 cents versus the Zacks Consensus Estimate of a loss of 1 cent and revenues of $18.8 million versus the estimate of $18.7 million. But the call’s main takeaway was the visibility management says it now has into a much larger revenue year ahead. Aehr Test Systems price-consensus-eps-surprise-chart | Aehr Test Systems Quote President and CEO Gayn Erickson said the company entered fiscal 2027 with strong momentum, citing record quarterly bookings, record backlog and rising demand across wafer-level and package-level burn-in. He framed those trends as the base for a multiyear growth setup rather than a one-quarter rebound. Management guided fiscal 2027 revenues of $130 million to $150 million, or about 2.6 times to 3 times fiscal 2026 revenues, with non-GAAP pretax profitability of 18% to 22%. CFO Chris Siu said the outlook reflects current backlog and anticipated customer demand. The quarter’s reported numbers helped support that message. Revenues rose 34% year over year, while non-GAAP net income reached $3.6 million versus a loss a year earlier. Erickson said nearly 95% of fiscal 2026 revenues came from markets outside electric-vehicle silicon carbide, a sharp change from two years ago. He identified AI accelerators, CPUs and network processors as the fastest-growing end market, accounting for about 71% of annual revenue. He also said the lead AI wafer-level customer has moved all production burn-in screening to wafer level on Aehr systems and is forecasting higher capacity needs. That customer has doubled its systems and added automated aligners, underscoring how central AI has become to the company’s story. In package-level burn-in, Erickson said the lead hyperscale customer is expanding Sonoma purchases for a second device with twice the power of the first. He added that Sonoma systems and consumables could become a larger revenue contributor as those devices ramp. One of the call’s more important updates came from a benchmark with a major supplier of AI accelerators, CPUs and network processors. Erickson said Aehr completed testing on…Read full documentShow less
Aehr Test Systems, Inc. AEHR used its fourth-quarter 2026 call to focus less on the quarter itself and more on the scale of demand it sees building into fiscal 2027. Management tied that outlook to AI processors, silicon photonics and a record-effective backlog.The company still posted a headline beat, with adjusted EPS of 11 cents versus the Zacks Consensus Estimate of a loss of 1 cent and revenues of $18.8 million versus the estimate of $18.7 million. But the call’s main takeaway was the visibility management says it now has into a much larger revenue year ahead. Aehr Test Systems price-consensus-eps-surprise-chart | Aehr Test Systems Quote President and CEO Gayn Erickson said the company entered fiscal 2027 with strong momentum, citing record quarterly bookings, record backlog and rising demand across wafer-level and package-level burn-in. He framed those trends as the base for a multiyear growth setup rather than a one-quarter rebound. Management guided fiscal 2027 revenues of $130 million to $150 million, or about 2.6 times to 3 times fiscal 2026 revenues, with non-GAAP pretax profitability of 18% to 22%. CFO Chris Siu said the outlook reflects current backlog and anticipated customer demand. The quarter’s reported numbers helped support that message. Revenues rose 34% year over year, while non-GAAP net income reached $3.6 million versus a loss a year earlier. Erickson said nearly 95% of fiscal 2026 revenues came from markets outside electric-vehicle silicon carbide, a sharp change from two years ago. He identified AI accelerators, CPUs and network processors as the fastest-growing end market, accounting for about 71% of annual revenue. He also said the lead AI wafer-level customer has moved all production burn-in screening to wafer level on Aehr systems and is forecasting higher capacity needs. That customer has doubled its systems and added automated aligners, underscoring how central AI has become to the company’s story. In package-level burn-in, Erickson said the lead hyperscale customer is expanding Sonoma purchases for a second device with twice the power of the first. He added that Sonoma systems and consumables could become a larger revenue contributor as those devices ramp. One of the call’s more important updates came from a benchmark with a major supplier of AI accelerators, CPUs and network processors. Erickson said Aehr completed testing on one processor and produced results that exceeded the customer’s expectations. That customer now wants to move to pilot production validation in Taiwan for a current high-volume device, and it has also asked Aehr to evaluate a second device in parallel. Erickson said the revenue opportunity from either device could be significant over both the near and long term. During Q&A, management made clear that little to none of this potential contribution is embedded in current guidance, leaving it positioned as upside rather than a core assumption. Beyond AI compute, Erickson highlighted silicon photonics as another key growth lane. He said the lead silicon photonics customer is ramping automated wafer-level systems, while a newer major networking customer has already ordered systems and forecast additional demand this calendar year. Power semiconductors also remained part of the forward narrative. Management said it completed more than a dozen gallium nitride WaferPak designs, sold its first silicon MOSFET wafer-level burn-in system and saw signs of recovery in silicon carbide. The press release added that Aehr received about $8 million of new silicon carbide wafer-level burn-in orders in the last month, including an order tied to one of the world’s largest automotive companies. Analysts pressed management on what sits inside the new guide. A Craig-Hallum analyst asked about revenue mix, and Erickson said AI should remain roughly 70% of the business, silicon photonics about 15% to 20%, with power and other markets making up the rest. He also said memory is not assumed, even at the top end of guidance. A William Blair analyst asked about timing, and Siu said the second quarter should be especially strong because of package-level Sonoma shipments. Erickson added that the first quarter has started well, while the second quarter should be bigger. On consumables, management told analysts that WaferPaks and burn-in module boards should remain about 30% of revenues. That matters because it points to a recurring element inside what could otherwise look like a systems-heavy ramp. The closing impression from the call was that management is preparing for demand rather than defending the current base. Siu pointed to capacity additions in Southeast Asia and an expanded Taiwan presence, while Erickson said the company is not capacity-constrained even at the high end of current guidance. That posture matched the balance sheet. Aehr ended the quarter with $116.5 million in cash, cash equivalents and restricted cash after raising about $100 million during fiscal 2026, giving it added flexibility to support larger customer programs. AEHR carries a Zacks Rank #3 (Hold). Based on Zacks’ framework, a Rank #3 can be held, but the strongest setups typically combine a Zacks Rank #1 (Strong Buy) or #2 (Buy) with Style Scores of A or B. You can see the complete list of today’s Zacks #1 Rank stocks here. The stock’s Value Score of F, Growth Score of F and VGM Score of F point to weak cross-style characteristics, while its Momentum Score of B indicates a more favorable trend profile than its value or growth readings. Zacks also notes that estimate revisions drive the rank, so that rating can change after earnings as analysts update forecasts. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aehr Test Systems (AEHR) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research
Investor releaseQuarter not tagged2026-07-14Aehr Test Systems Fiscal Q4 Swings to Earnings, Revenue Rises
MT Newswires
Aehr Test Systems Fiscal Q4 Swings to Earnings, Revenue Rises
Aehr Test Systems (AEHR) reported fiscal Q4 adjusted earnings late Tuesday of $0.11 per diluted shar
Investor releaseQuarter not tagged2026-07-14Aehr Test Systems (AEHR) Beats Q4 Earnings and Revenue Estimates
Zacks
Aehr Test Systems (AEHR) Beats Q4 Earnings and Revenue Estimates
Aehr Test Systems (AEHR) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +1,200.00%. A quarter ago, it was expected that this company would post a loss of $0.08 per share when it actually produced a loss of $0.05, delivering a surprise of +37.5%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Aehr Test Systems, which belongs to the Zacks Electronics - Measuring Instruments industry, posted revenues of $18.84 million for the quarter ended May 2026, surpassing the Zacks Consensus Estimate by 0.72%. This compares to year-ago revenues of $14.09 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Aehr Test Systems shares have added about 236.9% since the beginning of the year versus the S&P 500's gain of 9.8%. While Aehr Test Systems has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Aehr Test Systems was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the com…Read full documentShow less
Aehr Test Systems (AEHR) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +1,200.00%. A quarter ago, it was expected that this company would post a loss of $0.08 per share when it actually produced a loss of $0.05, delivering a surprise of +37.5%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Aehr Test Systems, which belongs to the Zacks Electronics - Measuring Instruments industry, posted revenues of $18.84 million for the quarter ended May 2026, surpassing the Zacks Consensus Estimate by 0.72%. This compares to year-ago revenues of $14.09 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Aehr Test Systems shares have added about 236.9% since the beginning of the year versus the S&P 500's gain of 9.8%. While Aehr Test Systems has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Aehr Test Systems was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.05 on $14.6 million in revenues for the coming quarter and $0.16 on $86.6 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Electronics - Measuring Instruments is currently in the top 8% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. inTest Corporation (INTT), another stock in the same industry, has yet to report results for the quarter ended June 2026. This company is expected to post quarterly earnings of $0.10 per share in its upcoming report, which represents a year-over-year change of +233.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. inTest Corporation's revenues are expected to be $33 million, up 17.3% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aehr Test Systems (AEHR) : Free Stock Analysis Report inTest Corporation (INTT) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

